Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-07
2006-11-07
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S305100, C548S310700
Reexamination Certificate
active
07132440
ABSTRACT:
2-Aryl substituted benzimidazoles and imidazo[4,5]pyridines are disclosed as inhibitors of Cds1 and useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer.
REFERENCES:
patent: 5059621 (1991-10-01), Shroot et al.
patent: 6310082 (2001-10-01), Griffin et al.
patent: 2003/0100582 (2003-05-01), Sircar et al.
patent: 2003/0176438 (2003-09-01), Arienti et al.
patent: 0148431 (1985-07-01), None
patent: 0209707 (1987-01-01), None
patent: 0719765 (1996-07-01), None
patent: WO 9806703 (1998-02-01), None
patent: WO 9911627 (1999-03-01), None
patent: WO 9930710 (1999-06-01), None
patent: WO 9961019 (1999-12-01), None
patent: WO 9961020 (1999-12-01), None
patent: WO 0100587 (2001-01-01), None
patent: WO 0121771 (2001-03-01), None
patent: WO 0153268 (2001-07-01), None
patent: WO 0174786 (2001-10-01), None
patent: WO 02/072090 (2002-09-01), None
patent: WO 03011219 (2003-02-01), None
patent: WO 03/028724 (2003-04-01), None
patent: WO 03/032984 (2003-04-01), None
patent: WO 0393297 (2003-11-01), None
patent: WO 0411439 (2004-02-01), None
patent: WO 0441209 (2004-05-01), None
Kim, J. S., et al. Structure-Activity Relationships of Benzimidazoles and Related Heterocycles as Topoisomerase I Poisons, 1996, Bioorg. Med. Chem. 4(4), pp. 621-630.
White, A.W., et al., “Resistance-modifying agents. 9. Synthesis and biologicalproperties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase”, Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 43, No. 2, Nov. 2, 2000, pp. 4084-4097.
PCT International Search Report, dated Aug. 26, 2004, for PCT Int'l Appln. No. PCT/US2004/011775.
Blasina, A. et al. A Human Homologue of the Checkpoint Kinase Cds1 Directly Inhibits Cdc25 Phosphatase. Curr. Biol. (1999) 9(1):1-10.
Buscemi, G. et al. Chk2 Activation Dependence on Nbs1 after DNA Damage. Mol. Cell. Biol. (2001) 21(15):5214-5222.
Falck, J. et al. The ATM-Chk2-Cdc25A Checkpoint Pathway Guards against Radioresistant DNA Synthesis. Nature (London) (2001) 410:842-847.
Hirao, A. et al. Chk2 Is a Tumor Suppressor That Regulates Apoptosis in both an Ataxia Telangiectasia Mutated (ATM)-Dependent and an ATM-Independent Manner. Mol. Cell. Biol. (2002) 22(18):6521-6532.
Kim, J.S. et al. Structure-Activity Relationships of Benzimidazoles and Related Heterocycles as Topoisomerase I Poisons. Bioorg. Med. Chem. (1996) 4(4):621-630.
Lee, J.-S. et al. hCds1-Mediated Phosphorylation of BRCA1 Regulates the DNA Damage Response. Nature (London) (2000) 404:201-204.
Matsuoka, S. et al. Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase. Science (Washington, D.C.) (1998) 282:1893-1897.
Takai, H. et al. Chk2-Deficient Mice Exhibit Radioresistance and Defective p53-Mediated Transcription. EMBO J. (2002) 21(19):5195-5205.
Tawar, U. et al. Influence of Phenyl Ring Distribution on Bisbenzimidazole and Terbenzimidazole Cytotoxicity: Synthesis and Biological Evaluation as Radioprotectors. J. Med. Chem. (2003) 48(18): 3785-3792.
Tominaga, K. et al. Role of Human Cds1 (Chk2) Kinase in DNA Damage Checkpoint and Its Regulation by p53. J. Biol. Chem. (1999) 274(44):31463-31467.
Arienti, K.L. et al. Checkpoint Kinase Inhibitors: SAR and Radiprotective Properties of a Series of 2-Arylbenzimidazoles. J. Med. Chem. 2005, 48, 1873-1885.
Ameriks Michael K.
Arienti Kristen L.
Axe Frank U.
Breitenbucher J. Guy
Grazier Nyeemah
Janssen Pharmaceutica N.V.
Saeed Kamal A.
LandOfFree
Substituted benzimidazoles and imidazo-[4,5]-pyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzimidazoles and imidazo-[4,5]-pyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzimidazoles and imidazo-[4,5]-pyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3643794